HD

Hadi Danaee

Vice President And Head, Translational Sciences And Clinical Biomarkers at HotSpot Therapeutics

Hadi Danaee is a highly experienced professional in the field of Translational Medicine and Clinical Biomarkers. With a strong background in leading biomarker and companion diagnostic strategies, Hadi has held key positions at various renowned pharmaceutical companies such as HotSpot Therapeutics, Inc., Blueprint Medicines, TESARO/GSK, Takeda Pharmaceuticals International Co., and Millennium Pharmaceuticals. With a solid educational foundation from Harvard T.H. Chan School of Public Health and University of Connecticut, Hadi has demonstrated expertise in developing and implementing biomarker strategies for oncology programs, as well as leading research in molecular medicine.

Links

Previous companies

Blueprint Medicines logo

Org chart

Peers

Timeline

  • Vice President And Head, Translational Sciences And Clinical Biomarkers

    January, 2022 - present

View in org chart